Liraglutide, which was originally developed for diabetes management, may result in nausea, vomiting and diarrhoea
For people aged 18-29, only 1% had ever used GLP-1 drugs to treat chronic conditions, while 7% of those in this age group had used them for weight loss, and a further 3% had used them for chronic conditions and weight loss
In dermatological contexts, the most clinically relevant gene targets include: COL1A1 and COL3A1 upregulation increases procollagen type I and III synthesis, directly counteracting age-related collagen depletion
They were used for 3D classification with masks focused on the TMD and the G protein
While some of these issues are minor, others may require a type of surgery to either resolve the issue or to make living with the health problem more bearable